Results 151 to 160 of about 2,911,119 (244)

Conversion Surgery After Administration of a TRK Inhibitor for Unresectable Parotid Gland Secretory Carcinoma. [PDF]

Head Neck
Nagano A, Matoba T, Kawakita D, Minohara K, Iwaki S, Tsuge H, Tsukamoto K, Kikuchi S, Nakano S, Murase T, Tada Y, Iwasaki S.   +11 more
europepmc   +1 more source

Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation. [PDF]

Prostate
Igarashi T, Mizoguchi S, Matsuoka K, Kamijo T, Kawano S, Furuta A, Suzuki Y, Kimura T, Pascal LE, Wang Z, Yoshimura N.   +10 more
europepmc   +1 more source

Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate [PDF]

, 2020
openaire   +1 more source

Die neuroprotektive Wirkung von Opioiden wird durch die Proteinkinase B / AKT vermittelt [PDF]

, 2010
Heiß, Anika
core  

The Novel Selective Pan-TRK Inhibitor ONO-7579 Exhibits Antitumor Efficacy Against Human Gallbladder Cancer In Vitro.

Anticancer Research, 2018
M. Kawamoto, K. Ozono, Yasuhiro Oyama, A. Yamasaki, Y. Oda, H. Onishi   +5 more
semanticscholar   +1 more source

Tropomyosin 3 Gene Fusions in Cancers: From Mechanisms to Treatments-A Comprehensive Review. [PDF]

Cancer Med
Chen A, Li S, Guo C, Gu C, Gui J, Deng Y, Feng X, Mi Y.   +7 more
europepmc   +1 more source

LMNA-NTRK1-rearranged spindle cell neoplasm with multiple relapses: a case report and literature review. [PDF]

Front Med (Lausanne)
Zhu Y, Wang Z, Xi H, Lu W, Sun M, Lin X.
europepmc   +1 more source

Bioanalytical assay for the novel TRK inhibitor selitrectinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019
R. Sparidans, Wenlong Li, A. Schinkel, J. Beijnen   +3 more
semanticscholar   +1 more source

Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to larotrectinib in GIST with NTRK fusion: a case report. [PDF]

Cell Oncol (Dordr)
Shen Y, Peng Q, Wen J, Yang L, Zhu L, Chen Y, Liu Q, Wang L, Yao J, Li A, Wang M, Liu Z.   +11 more
europepmc   +1 more source

Efficacy of larotrectinib in pediatric cancers with <i>NTRK</i> gene fusions. [PDF]

Transl Pediatr
Houghton PJ, Bjornsti MA.
europepmc   +1 more source